Evidence map›Paper›PMID 36547678›Full record

Observational studyWorld journal of urology2023

Non-papillary prone percutaneous nephrolithotomy for renal abnormalities: single-institution experience.

Arman Tsaturyan, Solon Faitatziadis, Angelis Peteinaris, Constantinos Adamou, Konstantinos Pagonis, Anastasios Natsos, Theofanis Vrettos, Evangelos Liatsikos, Panagiotis Kallidonis

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in World journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 3 countries.

Arman TsaturyanDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece. tsaturyanarman@yahoo.com.ORCID http://orcid.org/0000-0002-2499-7015
Solon FaitatziadisDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
Angelis PeteinarisDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
Constantinos AdamouDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
Konstantinos PagonisDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
Anastasios NatsosDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
Theofanis VrettosDepartment of Anesthesiology and ICU, University of Patras, Patras, Greece.
Evangelos LiatsikosDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
Panagiotis KallidonisDepartment of Urology, University of Patras Medical School, 26500, Rio, Patras, Greece.
University of Patras · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the effectiveness and safety of non-papillary prone PCNL for the treatment of patients with renal abnormalities.

methodsAn observational retrospective cohort study including PCNL cases of patients with renal abnormalities was performed. The following inclusion criteria were applied: renal stones > 1.5 cm with maximal diameter, anatomical malformations of affected kidney (malrotated kidneys, horseshoe kidneys and kidneys with complete duplicated systems, medullary sponge kidney), patients treated with standard (30Fr) PCNL or mini-PCNL (22Fr). The lithotripsy was performed using the Lithoclast Master or the Lithoclast

resultsOverall, 57 patients, 35 males, and 22 females with any renal malformation underwent non-papillary prone PCNL. Our study included 25 patients with horseshoe kidneys, 21 with malrotated kidneys, 9 with kidneys with duplicated pelvicalyceal systems and 2 with medullary sponge kidneys. The mean cumulative stone size was 36 ± 1.4 mm and most of the stones were in the lower calyceal group (36.9%) and in the pelvis (27.2%). The stone-free rate (SFR) was 84.2% and the mean hospitalization time was 2.7 ± 0.7 days. In total, postoperative complications were developed in six patients (10.5%), half of them presenting fever and the other half requiring blood transfusion (Grade II).

conclusionThe PCNL is the method of choice for treating large stones in anomalous kidneys. The generally accepted panacea that only a papillary puncture is safe is questioned by our results. Based on our experience, a non-papillary puncture proved to be a safe and effective procedure.

Indexed as

Fused KidneyKidney CalculiNephrolithotomy, PercutaneousNephrostomy, PercutaneousFemaleHumansKidneyMaleRetrospective StudiesTreatment OutcomeUrogenital AbnormalitiesHorseshoe kidneyMalrotated kidneyNon-papillary puncturePercutaneous nephrolithotomyRenal abnormality

Identifiers

PMID36547678
OpenAlexW4312069599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.